<i>In Vivo</i> phenotyping of tumor metabolism in a canine cancer patient with simultaneous <sup>18</sup>F-FDG-PET and hyperpolarized <sup>13</sup>C-Pyruvate magnetic resonance spectroscopic imaging (hyperPET):mismatch demonstrates that FDG may not always reflect the Warburg effect by Borgwardt, Henrik Gutte et al.
u n i ve r s i t y  o f  co pe n h ag e n  
Københavns Universitet
In Vivo phenotyping of tumor metabolism in a canine cancer patient with simultaneous
18F-FDG-PET and hyperpolarized 13C-Pyruvate magnetic resonance spectroscopic
imaging (hyperPET)
Borgwardt, Henrik Gutte; Hansen, Adam Espe; Estrup Larsen, Majbritt Maria; Rahbek, Sofie;
Johannesen, Helle Hjorth; Ardenkjaer-Larsen, Jan; Kristensen, Annemarie Thuri; Højgaard,
Liselotte; Kjær, Andreas
Published in:
Diagnostics
DOI:
10.3390/diagnostics5030287
Publication date:
2015
Document version
Publisher's PDF, also known as Version of record
Citation for published version (APA):
Borgwardt, H. G., Hansen, A. E., Estrup Larsen, M. M., Rahbek, S., Johannesen, H. H., Ardenkjaer-Larsen, J.,
... Kjær, A. (2015). In Vivo phenotyping of tumor metabolism in a canine cancer patient with simultaneous 18F-
FDG-PET and hyperpolarized 13C-Pyruvate magnetic resonance spectroscopic imaging (hyperPET): mismatch
demonstrates that FDG may not always reflect the Warburg effect. Diagnostics, 5(3), 287-289.
https://doi.org/10.3390/diagnostics5030287
Download date: 03. Feb. 2020
Diagnostics 2015, 5, 287-289; doi:10.3390/diagnostics5030287 
 
diagnostics 
ISSN 2075-4418 
www.mdpi.com/journal/diagnostics/ 
Interesting Images 
In Vivo Phenotyping of Tumor Metabolism in a Canine Cancer 
Patient with Simultaneous 18F-FDG-PET and Hyperpolarized 
13C-Pyruvate Magnetic Resonance Spectroscopic Imaging 
(hyperPET): Mismatch Demonstrates that FDG may not Always 
Reflect the Warburg Effect 
Henrik Gutte 1, Adam E. Hansen 1, Majbrit M.E. Larsen 2, Sofie Rahbek 1,  
Helle H. Johannesen 1, Jan Ardenkjaer-Larsen 3,4, Annemarie T. Kristensen 2,  
Liselotte Højgaard 1 and Andreas Kjaer 1,* 
1 Department of Clinical Physiology, Nuclear Medicine & PET and Cluster for Molecular Imaging, 
Rigshospitalet, University of Copenhagen, Copenhagen 2100, Denmark;  
E-Mails: gutte@sund.ku.dk (H.G.); adam.espe.hansen@regionh.dk (A.E.H.); 
sofie89falko@gmail.com (S.R.); helle.hjorth.johannesen.01@regionh.dk (H.H.J.); 
liselotte.hoejgaard@regionh.dk (L.H.) 
2 Department of Veterinary Clinical and Animal Sciences, Faculty of Health and Medical Sciences, 
University of Copenhagen, Frederiksberg C 2000, Denmark;  
E-Mails: majbritt.larsen@sund.ku.dk (M.M.E.L.); atk@sund.ku.dk (A.T.K.) 
3 Department of Electrical Engineering, Technical University of Denmark, Lyngby 2800, Denmark; 
E-Mail: JanHenrik.ArdenkjaerLarsen@ge.com 
4 GE Healthcare, Brøndby 2605, Denmark 
* Author to whom correspondence should be addressed; E-Mail: akjaer@sund.ku.dk;  
Tel.: +45-3545-4216; Fax: +45-3545-4015. 
Academic Editor: Graham Jackson 
Received: 13 May 2015 / Accepted: 19 June 2015 / Published: 26 June 2015 
 
Abstract: In this communication the mismatch between simultaneous 18F-FDG-PET and a 
13C-lactate imaging (hyperPET) in a biopsy verified squamous cell carcinoma in the right 
tonsil of a canine cancer patient is shown. The results demonstrate that 18F-FDG-PET may 
not always reflect the Warburg effect in all tumors. 
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Figure 1. HyperPET is a new in vivo imaging modality that consists of combining a  
PET scan with magnetic resonance spectroscopic imaging (MRSI) of hyperpolarized  
13C-pyruvate made possible by integrated hybrid PET/MRI systems [1]. The metabolism of 
cancer cells is characterized by a shift to glycolysis with production of lactate even in the 
presence of sufficient oxygen, this phenomenon is also known as the Warburg effect [2–4]. 
With the introduction of hyperpolarized 13C-pyruvate/13C-lactate MRSI it is probably now 
possible to directly study the metabolism of lactate and Warburg effect in real time. This is 
opposed to imaging with 18F-FDG PET scan alone, which demonstrates the Warburg effect 
only indirectly through increased glucose utilization and uptake. In Figure 1, 18F-FDG-PET 
and 13C-lactate MRSI in a spontaneous canine tumor is shown. A clear mismatch between  
18F-FDG uptake and 13C-lactate production is seen. In an axial slice of the neck in a canine 
cancer patient with a biopsy verified squamous cell carcinoma in the right tonsil,  
we noticed in panel A clear discrepancy between the 18F-FDG-PET (18F-FDG activity is 
shown in grey scale and the dashed arrow points at the margin of tumor) and the  
13C-lactate production (red to yellow color corresponds to the 13C-Lactate production and 
the arrow points to the margin of tumor) in a large heterogeneous tumor. 18F-FDG uptake in 
the tumor was variable in the tumor (panel C) and corresponded to the anatomical MR 
images in that high 18F-FDG levels paralleled the uptake of Gadolinium in the T1 sequence 
(panel B, dashed line outlines the contour of the tumor). However 13C-lactate did not 
correspond to the 18F-FDG uptake, especially in the more profound region of the tumor 
where we demonstrated a large production of 13C-lactate indicating higher degree of 
glycolysis (panel D). The Ethics and Administrative Committee, Department of Veterinary 
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Clinical and Animal Sciences, Faculty of Health and Medical Sciences, University of 
Copenhagen approved the study. Whereas 18F-FDG-PET has generally been accepted as an 
indicator of the Warburg effect the hyperPET imaging of a canine tumor demonstrates that 
this may not always be the case. Accordingly, the new technique of hyperPET that we 
recently introduced can expose such diversity in metabolism. We suggest that hyperPET 
may become a valuable tool for better phenotyping of tumors to be used for prognostication, 
treatment planning and response monitoring. 
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